Searchable abstracts of presentations at key conferences in endocrinology

ea0090p313 | Calcium and Bone | ECE2023

Permanent Hypoparathyroidism Consecutive to Thyroidectomy: Clinical Characterization in a Tertiary Center in Quito-Ecuador

Baquero Stefany , Guevara Gabriela , Villota Acosta Xavier , Ruiz Urbaez Rossana , Garcia Cristhian , Palacios Antonio , Luis Salazar Vega Jorge

Background: Acquired hypoparathyroidism due to thyroid surgery for thyroid cancer is the most common postsurgical etiology in a tertiary health center in Ecuador. Therefore, the data published from our country is limited. An observational cross-sectional study was carried out to determine the clinical, biochemical and therapeutic characteristics of patients with permanent hypoparathyroidism in the endocrinology department.Results: 102 patients were inclu...

ea0090ep804 | Pituitary and Neuroendocrinology | ECE2023

Correlation Betwen Obesity in Patients with A Diagnosis of Non-Functioning Adenomas and Prolactinomas

Baquero Stefany , Quishpe Lopez Darlyng , Freire Salazar Gabriela , Luis Salazar Vega Jorge , Ruiz Urbaez Rossana , Villota Acosta Xavier

Background : Obesity is a chronic and complex health problem. Although it is a preventable health risk factor, it´s prevalence has grown rapidly in recent years. There are studies that demonstrate the relationship between hyperprolactinemia and obesity. However, it is not well explained and the results are contradictory. The objective of this study was to evaluate the relationship between increased prolactin and Body Mass Index (BMI) in patients with pituitary macroadenom...

ea0025pl5biog | Society for Endocrinology European Medal Lecture 2011 | SFEBES2011

Society for Endocrinology European Medal Lecture 2011

Bertagna Xavier

Xavier Bertagna, Cochin Hospital, Paris, France. AbstractXavier Bertagna is Professor of Endocrinology, Chief of the Department of Endocrinology of Cochin hospital, Faculté de Médecine René Descartes, Université Paris, Paris, France.He trained at the Clinical Research Center (Dr. M. Chrétien), Montreal, Canada and at the Endocrine Division, Vanderbilt Medical School (Dr....

ea00100p8 | Poster Presentations | SFEEU2024

A case of connshing syndrome in northern ireland

Acosta Allan

Section 1: Case History: A case of 51 year old female who was referred to us by GP due to increase in size of previously known adrenal adenoma that was picked up on the abdominal ultrasound requested by GP for her deranged liver function test. She had previous investigations in 2017 by endocrinologist in another hospital for a left benign adrenal incidentiloma and it was found non-functional at that stage. She had hypertension 3 years ago and was started on Ramipril by GP. She...

ea0025pl5 | Society for Endocrinology European Medal Lecture 2011 | SFEBES2011

Genes and adrenal Cushing's syndrome: advance through European and world networks

Bertagna Xavier

Adrenal tumors – like many endocrine tumors – bear two classical threats: hormone hypersecretion and/or oncogenic potential. Also, because they are rare, their recognition may be delayed; and syndromic- or malignant tumors may be misdiagnosed…adding further threats…This talk will concentrate on recent progress brought by genetic studies with the aim of improving our understanding of the pathophysiology of these tumors, our diagnosti...

ea0025mte2 | (1) | SFEBES2011

Pitfalls in diagnosis and treatment of Cushing's syndrome

Bertagna Xavier

Many difficulties can be encountered in the management of patients with Cushing’s syndrome or suspected Cushing’s syndrome.In the first step of the diagnosis strategy, establishing the state of chronic hypercortisolism may be hampered by a number of pitfalls: drug interaction (inducers of high CBG levels, liver enzyme inducers, glucocorticoids, antiglucocorticoid RU 486, Glycyrrhetinic acid); intercurrent pathologic states (obesity, thyroid dys...

ea0020me8 | (1) | ECE2009

Cushing's syndrome: pitfalls in diagnosis and management

Bertagna Xavier

Drug interactions, intercurrent pathological states may interfere with routine diagnostic tests. Authentic hypercortisolic states can be present without Cushing’s syndrome, such as in depression, anorexia nervosa, alcoholism, pregnancy. Mild forms of Cushing’s syndrome, or fluctuating cases are other usual pitfalls.When the diagnosis of Cushing’s syndrome is firmly established there are still many potential pitfalls in the etiological diag...

ea0037ep1249 | Clinical Cases–Thyroid/Other | ECE2015

Adjustment disorder and hypertensive episodes associated with cross-sex treatment with testosterone

Arnas-Leon Claudia , Martinez-Martin Francisco Javier , Acosta-Calero Carmen , Perdomo-Herrera Esperanza

Introduction: Testosterone treatment in female-to-male transsexuals has been associated with worsened cardiovascular risk factors, acne, male-pattern baldness and more rarely with the onset of hypertension. Another frequent side effect of the treatment is aggression proneness -but rarely actual aggression- and increased libido.Case report: We present the case of a 17-year old transsexual patient referred for initiation of testosterone treatment. A low in...

ea0091p38 | Poster Presentations | SFEEU2023

Beneficial side effects: A case of difficult hyperthyroidism treated with Lithium

Acosta Allan , Hameed Ali

A case of a 48-year-old lady who is under follow-up in the clinic at Causeway Hospital, Northern Ireland for hyperthyroidism. She has a medical history of SLE under follow-up Rheumatologists and bronchial asthma. She presented with palpitations, tremors, sweating, and heat intolerance. On examination, the patient appears anxious. Blood pressure was 130/80, PR 140, RR 20, T 37, SPO2 98% A. Her eye examination revealed no lid lag, exophthalmos, and no redness. Examination of the...

ea0081p349 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

User acceptance and satisfaction with the eversense XL CGM in patients with type 1 diabetes

Javier Martinez Martin Francisco , Hernandez-Lazaro Alba , de Leon-Durango Ricardo , Kuzior Agnieszka , Arnas-Leon Claudia , Acosta-Calero Carmen

Objectives: Eversense XL is a fully implantable sensor for continuous glucose monitoring (CGM) that lasts for up to 180 days. Our objective was to perform a survey on user acceptance and satisfaction among our type 1 diabetic patients who had been using the Eversense XL CGM for at least 3 months.Methods: A questionnaire was devised in which the patients were asked about their experience with the Eversense XL CGM, including:-Compari...